320 related articles for article (PubMed ID: 15775666)
21. [Lambert-Eaton myasthenic syndrome (LEMS)].
Suzuki S
Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
[TBL] [Abstract][Full Text] [Related]
22. [Dosage and specificity of anti-calcium channel antibodies in Lambert-Eaton myasthenic syndrome].
Martin-Moutot N; de Haro L; Seagar M
Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S28-34. PubMed ID: 15269657
[TBL] [Abstract][Full Text] [Related]
23. [Proximal muscle weakness, depressed tendon reflexes and autonomic dysfunction: the Lambert-Eaton myasthenic syndrome].
Wirtz PW; Kuks JB; Wintzen AR; Verschuuren JJ
Ned Tijdschr Geneeskd; 2001 Jan; 145(2):57-61. PubMed ID: 11225256
[TBL] [Abstract][Full Text] [Related]
24. Lambert-Eaton myasthenic syndrome.
Newsom-Davis J
Rev Neurol (Paris); 2004 Feb; 160(2):177-80. PubMed ID: 15034474
[TBL] [Abstract][Full Text] [Related]
25. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
[TBL] [Abstract][Full Text] [Related]
26. Proteasome inhibitors for malignancy-related Lambert-Eaton myasthenic syndrome.
Wang C; Chen S; Feng B; Guan Y
Muscle Nerve; 2014 Mar; 49(3):325-8. PubMed ID: 24464710
[TBL] [Abstract][Full Text] [Related]
27. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
[TBL] [Abstract][Full Text] [Related]
28. Functional evaluation of inhibition of autonomic transmitter release by autoantibody from Lambert-Eaton myasthenic syndrome.
Houzen H; Hattori Y; Kanno M; Kikuchi S; Tashiro K; Motomura M; Nakao Y; Nakamura T
Ann Neurol; 1998 May; 43(5):677-80. PubMed ID: 9585366
[TBL] [Abstract][Full Text] [Related]
29. [Lambert-Eaton myasthenic syndrome, an immune pathology of neuromuscular junctions].
Honnorat J
Bull Acad Natl Med; 2014 Feb; 198(2):243-54; discussion 255. PubMed ID: 26263702
[TBL] [Abstract][Full Text] [Related]
30. Lambert-Eaton myasthenic syndrome. Clinical and electrophysiological findings in seven cases.
Zambelis T; Foutsitzi A; Giannakopoulou A; Poulopoulou K; Karandreas N
Electromyogr Clin Neurophysiol; 2004; 44(5):289-92. PubMed ID: 15378868
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer.
Rozsa C; Vincent A; Aranyi Z; Kovacs GG; Komoly S; Illes Z
Ideggyogy Sz; 2008 Sep; 61(9-10):325-8. PubMed ID: 18841652
[TBL] [Abstract][Full Text] [Related]
32. P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer.
Wirtz PW; Lang B; Graus F; van den Maagdenberg AM; Saiz A; de Koning Gans PA; Twijnstra A; Verschuuren JJ
J Neuroimmunol; 2005 Jul; 164(1-2):161-5. PubMed ID: 15904978
[TBL] [Abstract][Full Text] [Related]
33. Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
Payne M; Bradbury P; Lang B; Vincent A; Han C; Newsom-Davis J; Talbot D
J Thorac Oncol; 2010 Jan; 5(1):34-8. PubMed ID: 19934775
[TBL] [Abstract][Full Text] [Related]
34. Lambert-Eaton myasthenic syndrome: immunoglobulin G inhibition of Ca2+ flux in tumor cells correlates with disease severity.
Lang B; Vincent A; Murray NM; Newsom-Davis J
Ann Neurol; 1989 Mar; 25(3):265-71. PubMed ID: 2543262
[TBL] [Abstract][Full Text] [Related]
35. The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients.
Titulaer MJ; Wirtz PW; Kuks JB; Schelhaas HJ; van der Kooi AJ; Faber CG; van der Pol WL; de Visser M; Sillevis Smitt PA; Verschuuren JJ
J Neuroimmunol; 2008 Sep; 201-202():153-8. PubMed ID: 18644631
[TBL] [Abstract][Full Text] [Related]
36. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer.
Pelucchi A; Ciceri E; Clementi F; Marazzini L; Foresi A; Sher E
Am Rev Respir Dis; 1993 May; 147(5):1229-32. PubMed ID: 8387255
[TBL] [Abstract][Full Text] [Related]
37. Lambert-Eaton myasthenic syndrome in childhood.
Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A
Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
[TBL] [Abstract][Full Text] [Related]
38. SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma.
Lipka AF; Verschuuren JJ; Titulaer MJ
Ann N Y Acad Sci; 2012 Dec; 1275():70-7. PubMed ID: 23278580
[TBL] [Abstract][Full Text] [Related]
39. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
Titulaer MJ; Lang B; Verschuuren JJ
Lancet Neurol; 2011 Dec; 10(12):1098-107. PubMed ID: 22094130
[TBL] [Abstract][Full Text] [Related]
40. Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction.
Pellkofer HL; Voltz R; Kuempfel T
Muscle Nerve; 2009 Aug; 40(2):305-8. PubMed ID: 19609921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
